Abstract:Summary Background Multiple myeloma (MM) is an incurable hematological malignancy of the plasma cells. The maintenance of protein homeostasis is critical for MM cell survival. Elevated levels of paraproteins in MM cells are cleared by proteasomes or lysosomes, which are independent but inter-connected with each other. Proteasome inhibitors (PIs) work as a backbone agent and successfully improved the outcome of patients; however, the increasing activity of autophagy suppresses the sensitivity to PIs treatment. Methods The transcription levels of CRIP1 were explored in plasma cells obtained from healthy donors, patients with newly diagnosed multiple myeloma (NDMM), and relapsed/refractory multiple myeloma (RRMM) using Gene expression omnibus datasets. Doxycycline-inducible CRIP1-shRNA and CRIP1 overexpressed MM cell lines were constructed to explore the role of CRIP1 in MM pathogenesis. Proliferation, invasion, migration, proteasome activity and autophagy were examined in MM cells with different CRIP1 levels. Co-immunoprecipitation (Co-IP) with Tandem affinity purification/Mass spectrum (TAP/MS) was performed to identify the binding proteins of CRIP1. The mouse xenograft model was used to determine the role of CRIP1 in the proliferation and drug-resistance of MM cells. Findings High CRIP1 expression was associated with unfavorable clinical outcomes in patients with MM and served as a biomarker for RRMM with shorter overall survival. In vitro and in vivo studies showed that CRIP1 plays a critical role in protein homeostasis via the dual regulation of the activities of proteasome and autophagy in MM cells. A combined analysis of RNA-seq, Co-IP and TAP/MS demonstrated that CRIP1 promotes proteasome inhibitors resistance in MM cells by simultaneously binding to de-ubiquitinase USP7 and proteasome coactivator PA200. CRIP1 promoted proteasome activity and autophagosome maturation by facilitating the dequbiquitination and stabilization of PA200. Interpretation Our findings clarified the pivotal roles of the CRIP1/USP7/PA200 complex in ubiquitin-dependent proteasome degradation and autophagy maturation involved in the pathogenesis of MM. Funding A full list of funding sources can be found in the acknowledgements section.

Quantitative Proteomics Analysis on Biological Function of CRIP1

Identification of a Cisplatin Resistant-Based Prognostic Immune Related Gene Signature in MIBC

Cisplatin treatment leads to changes in nuclear protein and microRNA expression

Proteomic Analysis Identified Dj-1 As A Cisplatin Resistant Marker In Non-Small Cell Lung Cancer

Integrated Global Proteomic and Phosphoproteomic Analysis of Cisplatin-Induced Apoptosis in A549 Cells

Nuclear proteome analysis of cisplatin-treated HeLa cells

CRIF1 Promotes the Progression of Non-Small-cell Lung Cancer by SIRT3- Mediated Deacetylation of PYCR1.

Proteomics-based identification of secreted protein dihydrodiol dehydrogenase 2 as a potential biomarker for predicting cisplatin efficacy in advanced NSCLC patients

Comprehensive Analysis of CRIP1 in Patients with Ovarian Cancer, Including Cerna Network, Immune-Infiltration Pattern, and Clinical Benefit

GLIPR1 modulates the response of cisplatin-resistant human lung cancer cells to cisplatin

CRIP1 involves the pathogenesis of multiple myeloma via dual-regulation of proteasome and autophagy

Weighted Gene Coexpression Network Analysis Identifies Cysteine-Rich Intestinal Protein 1 (CRIP1) As a Prognostic Gene Associated with Relapse in Patients with Acute Myeloid Leukemia.

Overexpression of Chemokine Receptor Lymphotactin Receptor 1 Has Prognostic Value in Clear Cell Renal Cell Carcinoma

Proteomics-based Analysis of Differentially Expressed Proteins in the CXCR1-knockdown Gastric Carcinoma MKN45 Cell Line and Its Parental Cell

CRIM1, a Newfound Cancer-Related Player, Regulates the Adhesion and Migration of Lung Cancer Cells

Potential Regulatory Mechanism and Clinical Significance of Synaptotagmin Binding Cytoplasmic RNA Interacting Protein in Colorectal Cancer

The Role of CRYAB in Tumor Prognosis and Immune Infiltration: A Pan-cancer Analysis

XRCC1 Arg399Gln and Arg194Trp Polymorphisms Regulate XRCC1 Expression and Chemoresistance of Non-Small Cell Lung Cancer Cells

Proteins Associated with Cisplatin Resistance in Ovarian Cancer Cells Identified by Quantitative Proteomic Technology and Integrated with Mrna Expression Levels

Prognosis biomarker and potential therapeutic target CRIP2 associated with radiosensitivity in NSCLC cells

Deciphering the effects of PYCR1 on cell function and its associated mechanism in hepatocellular carcinoma